EU Third-Party Medicines
EU Audiences
All product information provided is intended for European Union audiences only. These products may not be available in all Member States of the EU or in countries outside the EU; they may be available under a different trademark, in different strengths, or for different indications. Countries outside the EU may have different regulatory and labeling requirements that would call for different information to be available.
Licensed EU Medicines
We have licensed medicines to third parties for commercialization, for which we receive royalties and/or manufacturing revenues. Such arrangements in the European Union include the following:
EU Medicines Using Alkermes' Technologies
We have granted licenses under our proprietary technologies to enable third parties to develop, commercialize and, in some cases, manufacture products for which we receive royalties and/or manufacturing revenues. Such arrangements with respect to products commercialized in the European Union include the following:
VUMERITY® is a registered trademark of Biogen MA Inc, used by Alkermes under license. VUMERITY is commercialized exclusively by Biogen. RISPERDAL CONSTA®, TREVICTA®, XEPLION® and BYANNLI® are registered trademarks of Johnson & Johnson or its affiliated companies.